6DC4
RSV-neutralizing human antibody AM22
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | NSLS BEAMLINE X6A |
| Synchrotron site | NSLS |
| Beamline | X6A |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2014-03-25 |
| Detector | ADSC QUANTUM 270 |
| Wavelength(s) | 1.000 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 64.240, 75.220, 109.010 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 32.720 - 1.700 |
| R-factor | 0.1812 |
| Rwork | 0.180 |
| R-free | 0.20490 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 3lmj 3qeg |
| RMSD bond length | 0.006 |
| RMSD bond angle | 0.836 |
| Data reduction software | MOSFLM (7.2.2) |
| Data scaling software | Aimless (0.7.1) |
| Phasing software | PHASER (2.8.0) |
| Refinement software | PHENIX (1.12_2829) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 32.720 | 1.730 |
| High resolution limit [Å] | 1.700 | 1.700 |
| Number of reflections | 58786 | 20172 |
| <I/σ(I)> | 17.4 | 2.3 |
| Completeness [%] | 100.0 | 100 |
| Redundancy | 7.1 | 6.5 |
| CC(1/2) | 0.999 | 0.714 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 293 | 0.02 M 1,6-Hexanediol, 0.02 M 1-Butanol, 0.02 M 1,2-Propanediol (racemic), 0.02 M 2-Propanol, 0.02 M 1,4-Butanediol, 0.02 M 1,3-Propanediol, 0.1 M MES/imidazole pH 6.5, 10% PEG 8000, 20% ethylene glycol |






